Position in GELS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$83
-$1,128 QoQ
Shares Held
125
-93.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 6 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GELS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. GELS ranks #78 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in GELS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83 | 125 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,211 | 1,834 | Shares | Defined | 2026-05-05 | |
| 2025-09-30 | $1,313 | 952 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,580 | 5,538 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,392 | 23,454 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $14,381 | 6,199 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||